Diabetic foot
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Agree to participate in the study (sign the informed consent form); diagnosis of type 1 or 2 diabetes; present chronic wounds (wounds that do not close after 6 weeks); grade 2 wound, according to Wagner's classification (DIABETIC FOOT ULCER CLASSIFICATION SYSTEMS, 2016), which is: neuropathic and deeper, often penetrating the subcutaneous tissue, has infection, but without bone involvement, purulent secretion, inflammation and cellulitis.
Exclusion criteria
Exclusion criteria: Ingesting any supplement that aids healing, in pre- and post-operative procedures (e.g. impact diet); infected ulcer accompanied by cellulitis; osteomyelitis; received or will receive radiation during the study; had constant alcohol abuse 3 months before the start of the research; diagnosed with cancer; presence of wounds containing necrotic tissue, slough or fibrin necrosis; and inability of the patient to continue attending the clinic during follow-up
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate whether the retraction (in percentage) of the diabetic foot wound area is improved after the combination of electrophysical devices and nanoparticle ointment when compared with conventional treatment (control) | — |
Secondary
| Measure | Time frame |
|---|---|
| To evaluate whether better wound retraction is related to anti-inflammatory and antioxidant markers and growth factors after the combination of electrophysical devices and nanoparticle ointment when compared with conventional treatment (control) | — |
Countries
Brazil
Contacts
Universidade Federal de Juiz de Fora